Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR

American Journal of Physiology - Renal Physiology

Volumn 275, Issue 4 44-4, 1998, Pages

  Kvam, Fred Ivan ^a,b   Ofstad, Jarle ^a   Iversen, Bjarne M ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiotensin converting enzyme inhibitor; Calcium channel antagonist; Hypertension; Renal blood flow; Renal hemodynamics; Renal micropuncture; 1 adrenergic receptor blocker

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOXAZOSIN; ENALAPRIL; NIFEDIPINE; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; AUTOREGULATION; CAPILLARY PRESSURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031785022     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.275.4.f576     Document Type: Article

References (36)

1. Anderson, S. Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass. Hypertension 17: 288-295, 1991.
2. Anderson, S., H. G. Rennke, and B. M. Brenner. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J. Clin. Invest. 77: 1993-2000, 1986.
3. Aukland, K., and H. M. Johnsen. A colloid osmometer for small fluid samples. Acta Physiol. Scand. 90: 485-490, 1977.
4. Bidani, A. K., M. M. Schwartz, and E. J. Lewis. Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am. J. Physiol. 252 (Renal Fluid Electrolyte Physiol. 21): F1003-F1010, 1987.
5. Brunner, F. B., G. Thiel, M. Hermle, H. A. Bock, and M. J. Mihatsch. Long-term enalapril and verapamil in rats with reduced renal mass. Kidney Int. 36: 969-977, 1989.
6. Cacellas, D., and L. C. Moore. Autoregulation and tubuloglomerular feedback in juxtamedullary glomerular arterioles. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F660-F669, 1990.
7. Chatziantoniou, C., and W. J. Arendshorst. Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F68-F76, 1992.
8. Dworkin, L. D., J. A. Benstein, M. Parker, E. Tolbert, and H. D. Feiner. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int. 43: 808-814, 1993.
9. Edwards, R. M. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am. J. Physiol. 244 (Renal Fluid Electrolyte Physiol. 13): F526-F534, 1983.
10. Fleming, J. T., N. Parekh, and M. Steinhausen. Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am. J. Physiol. 253 (Renal Fluid Electrolyte Physiol. 22): F1157-F1163, 1987.
11. Gertz, K. H., J. A. Mangos, G. Braun, and H. D. Pagel. Pressure in the glomerular capillaries of the rat kidney and its relation to arterial blood pressure. Pflügers Arch. 288: 369-374, 1966.
12. Griffin, K. A., M. Picken, and A. K. Bidani. Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J. Clin. Invest. 96: 793-800, 1995.
13. Griffin, K. A., M. Picken, and A. K. Bidani. Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney model. Kidney Int. 46: 1010-1018, 1994.
14. Harris, D. C. H., W. S. Hammond, T. J. Burke, and R. W. Schrier. Verapamil protects against progression of experimental chronic renal failure. Kidney Int. 31: 41-46, 1987.
15. Hermansson, K., M. Larson, Ö. Kallskog, and M. Wolgast. Influence of renal nerve activity on arteriolar resistance, ultrafiltration dynamics and fluid reabsorption. Pflügers Arch. 389: 85-90, 1981.
16. Intaglietta, M., R. F. Pawula, and W. R. Tompkins. Pressure measurements in the mammalian microvasculature. Microvasc. Res. 2: 212-220, 1970.
17. Ischikawa, I., J. F. Miele, and B. M. Brenner. Reversal of renal cortical actions of angiotensin II by verapamil and manganese. Kidney Int. 16: 137-147, 1979.
18. Iversen, B. M., K. Amann, F. I. Kvam, X. Wang, and J. Ofstad. Glomerulosclerosis in juxtamedullary cortex is mediated through increased glomerular capillary pressure and glomerular size in SHR Am. J. Physiol. 274 (Renal Physiol. 43): F365-F373, 1998.
19. Iversen, B. M., F. I. Kvam, K. Matre, L. Mørkrid, G. Horvei, W. Bagchus, J. Grond, and J. Ofstad. Effect of mesangiolysis on autoregulation of renal blood flow and glomerular filtration rate in rats. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F361-F366, 1992.
20. Iversen, B. M., I. Sekse, and J. Ofstad. Resetting of renal blood flow autoregulation in spontaneously hypertensive rats. Am. J. Physiol. 252 (Renal Fluid Electrolyte Physiol. 21): F480-F486, 1987.
21. Jackson, B., and C. I. Johnston. The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor. J. Hypertens. 6: 495-501, 1988.
22. Källskog, Ö., L. O. Lindbom, H. R. Ulfendal, and M. Wolgast. Hydrostatic pressures within the vascular structures of the rat kidney. Pflügers Arch. 363: 205-210, 1976.
23. Loutzenhiser, R., and M. Epstein. The renal hemodynamic effects of calcium antagonists. In: Calcium Antagonists and the Kidney, edited by M. Epstein and R. Loutzenhizer. Philadelphia, PA: Hanley Belfus, 1990, p. 33-73.
24. Mitchell, K. D., and L.G. Navar. Tubuloglomerular feedback responses during peritubular infusions of calcium channel blockers. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F537-F544, 1990.
25. Navar, L. G. Renal autoregulation: perspectives from whole kidney and single nephron studies. Am. J. Physiol. 234 (Renal Fluid Electrolyte Physiol. 3): F357-F370, 1978.
26. Navar, L. G., W. J. Champion, and C. E. Thomas. Effects of calcium channel blockade on renal vascular resistance responses to changes in perfusion pressure and angiotensin-converting enzyme inhibition in dogs. Circ. Res. 58: 874-881, 1986.
27. Nishikimi, T., K. Uchino, and E. D. Frohlich. Effects of ai-adrenergic blockade on intrarenal hemodynamics in heart failure rats. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31): R198-R203, 1992.
28. 1-adrenoceptor inhibition on intrarenal hemodynamics in SHR. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1437-R1442, 1994.
29. Ofstad, J., G. Horvei, F. I. Kvam, L. Mørkrid, I. Sekse, E. Svarstad, and B. M. Iversen. Glomerular hemodynamics in progressive renal disease. Kidney Int. 41, Suppl. 36: S8-S14, 1992.
30. Pelayo, J. C., M. G. Ziegler, and R. C. Blantz. Angiotensin II in adrenergic-induced alterations in glomerular hemodynamics. Am. J. Physiol. 247 (Renal Fluid Electrolyte Physiol. 16): F799-F807, 1984.
31. Schnermann, J., and J. P. Briggs. Effect of angiotensin and other pressor agents on tubuloglomerular feedback responses. Kidney Int. 30, Suppl.: S77-S80, 1990.
32. Schnermann, J., and J. P. Briggs. Interactions between loop of Henle flow and arterial pressure as determinants of glomerular pressure. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F421-F429, 1989.
33. Steinhausen, M., E. Karlhans, and D. L. Wiegman. Glomerular blood flow. Kidney Int. 38: 769-784, 1990.
34. Tolins, J. P., and L. Raij. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury. Hypertension 16: 452-461, 1990.
35. 1-Adrenergic receptor blockade reduces afferent and efferent glomerular arteriolar resistances in SHR. Am. J. Physiol. 261 (Regulatory Integratiue Comp. Physiol. 30): R576-R580, 1991.
36. Wenzel, U. O., G. Troschau, W. Schoeppe, U. Helmchen, and G. Schwietzer. Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension. Hypertension 20: 233-241, 1992.